Cargando…

Macrophages as tools and targets in cancer therapy

Tumour-associated macrophages are an essential component of the tumour microenvironment and have a role in the orchestration of angiogenesis, extracellular matrix remodelling, cancer cell proliferation, metastasis and immunosuppression, as well as in resistance to chemotherapeutic agents and checkpo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mantovani, Alberto, Allavena, Paola, Marchesi, Federica, Garlanda, Cecilia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380983/ https://www.ncbi.nlm.nih.gov/pubmed/35974096 http://dx.doi.org/10.1038/s41573-022-00520-5

Ejemplares similares

The interaction of anticancer therapies with tumor-associated macrophages
por: Mantovani, Alberto, et al.
Publicado: (2015)

Tumor-Associated Macrophages as Incessant Builders and Destroyers of the Cancer Stroma
por: Liguori, Manuela, et al.
Publicado: (2011)

Optical in vivo imaging detection of preclinical models of gut tumors through the expression of integrin αVβ3
por: Marelli, Giulia, et al.
Publicado: (2018)

Humoral Innate Immunity and Acute-Phase Proteins
por: Mantovani, Alberto, et al.
Publicado: (2023)

Tertiary Intratumor Lymphoid Tissue in Colo-Rectal Cancer
por: Bergomas, Francesca, et al.
Publicado: (2011)

A topology perspective on macrophages in melanoma metastasis
por: Mantovani, Alberto, et al.
Publicado: (2022)

Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting
por: Erreni, Marco, et al.
Publicado: (2023)

Intestinal Macrophages at the Crossroad between Diet, Inflammation, and Cancer
por: Caprara, Greta, et al.
Publicado: (2020)

Macrophages and cancer stem cells: a malevolent alliance
por: Allavena, Paola, et al.
Publicado: (2021)

Trabectedin: A drug from the sea that strikes tumor-associated macrophages
por: Allavena, Paola, et al.
Publicado: (2013)

Ligands and Receptors of the Interleukin-1 Family in Immunity and Disease
por: Garlanda, Cecilia, et al.
Publicado: (2013)

Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses
por: Anfray, Clément, et al.
Publicado: (2019)

Poly(I:C) stimulation is superior than Imiquimod to induce the antitumoral functional profile of tumor‐conditioned macrophages
por: Maeda, Akihiro, et al.
Publicado: (2019)

Pathogen Recognition by the Long Pentraxin PTX3
por: Moalli, Federica, et al.
Publicado: (2011)

The Dual Complexity of PTX3 in Health and Disease: A Balancing Act?
por: Magrini, Elena, et al.
Publicado: (2016)

Decoys and Regulatory “Receptors” of the IL-1/Toll-Like Receptor Superfamily
por: Garlanda, Cecilia, et al.
Publicado: (2013)

Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment
por: Liguori, Manuela, et al.
Publicado: (2016)

PTX3 orchestrates tissue repair
por: Doni, Andrea, et al.
Publicado: (2015)

PTX3 acts as an extrinsic oncosuppressor
por: Bonavita, Eduardo, et al.
Publicado: (2015)

TIR8/SIGIRR is an Interleukin-1 Receptor/Toll Like Receptor Family Member with Regulatory Functions in Inflammation and Immunity
por: Riva, Federica, et al.
Publicado: (2012)

Regulatory Role of IL-1R8 in Immunity and Disease
por: Molgora, Martina, et al.
Publicado: (2016)

Macrophages in Colorectal Cancer Liver Metastases
por: Cortese, Nina, et al.
Publicado: (2019)

Human Macrophage–derived Chemokine (MDC), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer Cells
por: Godiska, Ronald, et al.
Publicado: (1997)

Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer
por: Malesci, Alberto, et al.
Publicado: (2017)

Humoral innate immunity at the crossroad between microbe and matrix recognition: The role of PTX3 in tissue damage
por: Doni, Andrea, et al.
Publicado: (2017)

The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer
por: Doni, Andrea, et al.
Publicado: (2019)

Antitumor strategies targeting macrophages: the importance of considering the differences in differentiation/polarization processes between human and mouse macrophages
por: Monnier, Marine, et al.
Publicado: (2022)

Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer
por: Di Caro, Giuseppe, et al.
Publicado: (2016)

The “sweet” side of a long pentraxin: how glycosylation affects PTX3 functions in innate immunity and inflammation
por: Inforzato, Antonio, et al.
Publicado: (2013)

Macrophages as potential targets in gene therapy for cancer treatment
por: Huang, Yuanzheng, et al.
Publicado: (2023)

Oncogenic KRAS-Induced Protein Signature in the Tumor Secretome Identifies Laminin-C2 and Pentraxin-3 as Useful Biomarkers for the Early Diagnosis of Pancreatic Cancer
por: Kamal, Mohammad Azhar, et al.
Publicado: (2022)

Correction: Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer
por: Di Caro, Giuseppe, et al.
Publicado: (2016)

Macrophage-Derived Extracellular Vesicles: A Promising Tool for Personalized Cancer Therapy
por: Barone, Antonella, et al.
Publicado: (2022)

Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models
por: Belgiovine, Cristina, et al.
Publicado: (2017)

Engagement of the Mannose Receptor by Tumoral Mucins Activates an Immune Suppressive Phenotype in Human Tumor-Associated Macrophages
por: Allavena, P., et al.
Publicado: (2010)

The Long Pentraxin PTX3 as a Humoral Innate Immunity Functional Player and Biomarker of Infections and Sepsis
por: Porte, Rémi, et al.
Publicado: (2019)

Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials
por: Wang, Shuhang, et al.
Publicado: (2022)

Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy
por: Gupta, Vijayalaxmi, et al.
Publicado: (2018)

Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy
por: He, Yuanyuan, et al.
Publicado: (2021)

Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
por: Anfray, Clément, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r8oka1p8krk8m56v8a7jgbndnj